2017
DOI: 10.1002/cbic.201600665
|View full text |Cite
|
Sign up to set email alerts
|

Insights from NMR Spectroscopy into the Conformational Properties of Man‐9 and Its Recognition by Two HIV Binding Proteins

Abstract: Man9GlcNAc2 (Man-9) present at the surface of HIV constitutes the binding sites of several HIV neutralizing agents and mammalian lectin DC-SIGN that is involved in cellular immunity and trans-infections. We describe the conformational properties of Man-9 in free state and when bound by an HIV entry inhibitor protein and define the minimum epitopes of two HIV binding proteins using NMR spectroscopy. In this regard we developed a robust expression system for production of 13C,15N-labeled glycans in mammalian cel… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

4
24
1

Year Published

2018
2018
2022
2022

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 19 publications
(29 citation statements)
references
References 48 publications
4
24
1
Order By: Relevance
“…MVN binds to mannose-α(1-2)-mannose terminal glycans, including those on HIV-1 Env, with mutations Q81K and M83R further stabilizing interactions. [22][23][24]45,46 Man-α(1-2)-man-terminating glycans have been quantified on the cell surfaces of nontransfected HEK293 cells (8.4-12.8% of total glycans). 47,48 HEK293T cells stably express the SV40 large T antigen but otherwise resemble their parent 293 cell line.…”
Section: Off-target Effects Do Not Account For the Degree Of Observedmentioning
confidence: 99%
See 1 more Smart Citation
“…MVN binds to mannose-α(1-2)-mannose terminal glycans, including those on HIV-1 Env, with mutations Q81K and M83R further stabilizing interactions. [22][23][24]45,46 Man-α(1-2)-man-terminating glycans have been quantified on the cell surfaces of nontransfected HEK293 cells (8.4-12.8% of total glycans). 47,48 HEK293T cells stably express the SV40 large T antigen but otherwise resemble their parent 293 cell line.…”
Section: Off-target Effects Do Not Account For the Degree Of Observedmentioning
confidence: 99%
“…22 MVN* is a recombinant variant of the original lectin microvirin (MVN), containing Q81K and M83R mutations ( Figure 1B) that enhance MNV's ability to bind to mannose-α (1-2)-mannose terminating glycans on HIV-1 Env gp120 and has been shown to inhibit HIV-1 infection. 23,24 L4 describes the flexible peptide linker (G 4 S) 4 . Trp3 is a truncation of the HIV-1 Env membrane proximal external region (MPER) sequence at the third tryptophan [HxBc numbering 664-672 (see Figure 1C)], resulting in the peptide sequence DKWASLWNW.…”
mentioning
confidence: 99%
“…29 The discovery of MVN, a highly specific Manα-(1,2)-Man binding lectin, was reported in 2006 by Kehr et al 23 Since then, it has been investigated for anti-HIV-1 activity and as a neutralizing agent for hepatitis C viral infections. 24,30,31 To evaluate the feasibility of MVN to selectively capture ManLAM for use in next generation TB diagnostic tests, MVN was subjected to biolayer interferometry (BLI) experiments with procurable LAM variants. LAM antibodies procured from the BEI repository and FIND were also evaluated employing the same design of experiments.…”
Section: Resultsmentioning
confidence: 99%
“…2A). 30 Stability is an important parameter to the utility of proteinbased capture reagents, especially when employed in POC diagnostic tests. As a measure of stability, the binding affinity (K D ) of MVN conjugates, stored at room temp and at 4°C, was examined against H37Rv M. tb ManLAM over time.…”
Section: Resultsmentioning
confidence: 99%
“…Recently, the group of Kato and coworkers engineered a yeast cell line to produce Man-9 (Kamiya, Yamamoto, Chiba, Jigami, & Kato, 2011). For the studies described here, we developed a reliable method for purifying milligram quantities of Man-9 from recombinant gp120 produced in the presence of the A-mannosidase inhibitor kifunensine (Sastry, Bewley, & Kwong, 2015; Shahzad-Ul-Hussan et al, 2017). …”
Section: Selection Of the Glycan Targetmentioning
confidence: 99%